Last update 07 Dec 2024

UBG-T19

Overview

Basic Info

Drug Type
Universal CAR-T
Synonyms
Universal anti-CD19 CAR-T - Guangzhou Bio-gene Technology, UBG T19, UBG-T19
Target
CD19
Mechanism
CD19 inhibitors(B-lymphocyte antigen CD19 inhibitors), Immunologic cytotoxicity, T lymphocyte replacements
Therapeutic Areas
Immune System DiseasesSkin and Musculoskeletal DiseasesNeoplasms+ [2]
Active Indication
Systemic Lupus ErythematosusChronic Lymphocytic LeukemiaNon-Hodgkin Lymphoma+ [1]
Inactive Indication-
Originator Organization
Guangzhou Bio-gene Technology Co., Ltd.Guangzhou Bio-gene Technology Co., Ltd.
Active Organization
Guangzhou Bio-gene Technology Co., Ltd.Guangzhou Bio-gene Technology Co., Ltd.
Inactive Organization-
Drug Highest PhasePhase 1/2
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with UBG-T19
NCT06106906 / RecruitingPhase 1/2IIT
A Single-center Clinical Study Evaluating the Safety and Efficacy of CD19 CAR-T in Active Systemic Lupus Erythematosus
100 Clinical Results associated with UBG-T19
Login to view more data
100 Translational Medicine associated with UBG-T19
Login to view more data
100 Patents (Medical) associated with UBG-T19
Login to view more data
100 Deals associated with UBG-T19
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Systemic Lupus ErythematosusPhase 2
CN
Guangzhou Bio-gene Technology Co., Ltd.Guangzhou Bio-gene Technology Co., Ltd.
19 Jun 2024
Chronic Lymphocytic LeukemiaIND Application
CN
Guangzhou Bio-gene Technology Co., Ltd.Guangzhou Bio-gene Technology Co., Ltd.
25 Jul 2018
Non-Hodgkin LymphomaIND Application
CN
Guangzhou Bio-gene Technology Co., Ltd.Guangzhou Bio-gene Technology Co., Ltd.
25 Jul 2018
Pre B-cell acute lymphoblastic leukemiaIND Application
CN
Guangzhou Bio-gene Technology Co., Ltd.Guangzhou Bio-gene Technology Co., Ltd.
25 Jul 2018
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free